In immunology, something added to a vaccine or immune treatment to make the immune response stronger.Thymosin alpha-1 has been studied as a vaccine adjuvant for hepatitis B and influenza, particularly in immunocompromised patients who respond poorly to standard vaccination. Not to be confused with adjuvant therapy in oncology, which refers to treatment given after primary surgery to reduce recurrence risk — an entirely different use of the same word.